The purpose of this study was to investigate the relationship between the proportion of sperm chromatin linked to remaining histone and assisted reproductive technology (ART) outcome. A prospective cohort study was performed on couples undergoing ART process at the Department of Reproduction Medicine (HFME, Bron, France). The histone-to-protamine ratio (HPR) was measured using the method described by Wykes & Krawetz (2003) J Biol Chem 278, 29471. The correlations with sperm DFI, blastocyst formation, pregnancy rate, and delivery rate were investigated. A total of 291 ART cycles were included (42 c-IVF and 249 ICSI procedures): 3870 oocytes were punctured and 2211 embryos were obtained, among which 507 were transferred and 336 frozen. The mean HPR was 18.9%. A significant negative correlation was found between HPR and DFI (r = À0.12, p < 0.05). Regarding the type of ART procedure (c-IVF or ICSI), the same kind of relationship between HPR and ART parameters was observed. Regardless of the type of ART procedure used, when the HPR was within the range [6%; 26%], the blastocyst formation rate was higher: 87.8% vs. 71.2% (HPR<6%; p < 0.01) and 74.6% (HPR >26%; p < 0.01). The highest delivery rate (DR; 24.5%) was obtained for HPR within the range [6%; 26%]; DR was 21.9% for HPR<6% and 18.3% for HPR>26%; however, the differences were not statistically significant. The procedure described in this study seems to be a reliable evaluation of the HPR. The HPR parameter seems to be correlated to embryonic development up to the blastocyst stage, but its involvement in clinical pregnancy/delivery could not be confirmed. HPR should be further investigated for confirming the relationship with blastocyst formation. After this, the next step will be to investigate the etiologies of HPR alterations for improving the sperm nucleus quality for increasing the chance of pregnancy.
INTRODUCTION
The assessment of male fertility is essentially based on semen analysis according to the WHO criteria (WHO, 2010) , and, although other indicators such as sperm DNA fragmentation (Benchaib et al., 2003 (Benchaib et al., , 2007 are available, there is no consensus as to their use (Zhao et al., 2014; Ioannou et al., 2016) . More generally, these indicators do not allow clarification of all causes of male infertility, and therefore, new parameters are required to improve this situation.
During spermatogenesis, chromatin undergoes major structural transitions during condensation and installation of nuclear protamines. In humans and mice, two types of protamines (PRM1 and PRM2) are implicated in the compaction of chromatin. Histone nucleoproteins are first exchanged for transition proteins 1 and 2 (TNP1 and TNP2), which are later replaced by PRM1 and PRM2. During this process, double-stranded DNA is broken and subsequently repaired (Ramos et al., 2008) . Protamines are, in many species, the major proteins associated with nuclear DNA in the mature spermatozoon, and in humans, approximately 15% of sperm chromatin remains linked to histones in specific areas (Wykes & Krawetz, 2003) . One role of protamine is the protection of the sperm DNA (Balhorn, 2007) . There are two types of protamines, P1 and P2 (Balhorn, 2007) , and the P1/P2 ratio is altered in infertile patients (Zhang et al., 2006; Zini et al., 2007; Hammoud et al., 2009) . Studies also report that alterations of protamine content are observed in a subgroup of subfertile men (Balhorn et al., 1988; Aoki et al., 2005a,b; de Mateo et al., 2009) . Furthermore, a correlation has been found between sperm DNA fragmentation and altered P1/ P2 ratios but also protamine concentration (Aoki et al., 2005a,b) . Sperm protamination has also been correlated with fertilization rate during an artificial reproductive technology (ART) process (Esterhuizen et al., 2000; Aoki et al., 2006; Rogenhofer et al., 2013) .
The sperm protamine deficiency observed in infertile men suggests that the histone-to-protamine ratio (HPR) could be impacted. A relationship between HPR and male fertility in the absence of an altered P1/P2 ratio has been found (Zhang et al., 2006) , but the impact of HPR on fertilization rate, blastocyst formation, and pregnancy has not been studied.
In this context, the aim of this study was to investigate the relationship between HPR and fertilization rate, blastocyst formation, and delivery rate.
MATERIALS AND METHODS

Study design
A prospective cohort study was conducted in the department of reproductive medicine at the Hôpital Femme Mere Enfant, located in Bron (part of the Lyon teaching hospitals, France). The study was approved by the ethics committee of the hospital, and informed consent was obtained from all individual participants included in this study. Couples included in conventional in vitro fertilization (c-IVF) or intracytoplasmic sperm injection (ICSI) procedures during the study period (October 2013 to July 2015) were eligible; those with fewer than six punctured oocytes surgically extracted spermatozoa, frozen spermatozoa, leukocytes, or round cells present in the semen, or <30 million per ejaculate were not included. Age of either females or males was not an exclusion criterion. C-IVF or ICSI procedures were performed using fresh spermatozoa, and the remaining semen conserved at À20°C for this study. Among the 350 couples who consented, 59 were excluded. The reasons were as follows: number of punctured oocytes <6 (n = 15), spermatozoa concentration not allowing HPR measurement (n = 40), and leukocytes in semen (n = 4). Therefore, a total of 291 couples were included in the study between September 2013 and July 2015. Five sperm donors were included to validate the HPR values obtained with the protocol. These fertile donors have at least one biological child, and ten children were obtained using their (donor) spermatozoa during an ART procedure.
Ovarian stimulation
After three weeks of desensitization by gonadotropin-releasing hormone (GnRH) analogues (Decapeptyl Sperm preparation for ART procedure Semen was prepared using a discontinuous gradient of SupraSperm â (Origio, Malov, Denmark). The gradient consisted of three 1-mL layers of SupraSperm â : 90, 70, and 50%. A maximum of one mL of spermatozoa was placed on top of the 50% layer. The volume of deposited spermatozoa was defined according to the initial sperm concentration, with the aim of obtaining a final concentration of 1 million per mL progressive spermatozoa in case of ICSI and 7 million per mL in case of c-IVF. After centrifugation (300 g, 20 min) at room temperature, the 90% layer was collected and washed with 5 mL of FertiCult â flushing medium (FertiPro N.V., Beernem, Belgium) at 600 g for 10 min at room temperature. The pellet was suspended in IVF medium â (Scandinavian IVF, Gothenburg, Sweden) for IVF or FertiCult Flushing (FertiPro) for ICSI.
Embryo transfer
Sixteen to eighteen hours after insemination or microinjection, oocytes were evaluated for fertilization (2-pronuclei stage). Embryo transfer was performed either after 48 h (D2) or 72 h (D3, n = 131), or at the blastocyst stage (D5, n = 102, or D6, n = 35). The embryo transfer strategy was defined according to the cycle number. An early cleavage (D2 and D3) transfer was performed when the cycle number was less than three, independently of the retrieved oocyte number. When the embryo transfer was performed at D2 or D3, the supernumerary embryos were allowed to develop on G2 â medium (Irvine Scientific, Santa Ana, CA, USA) or BlastAssist â (Origio) to the blastocyst stage, and if one or more good-quality blastocysts were obtained, they were then cryopreserved. A blastocyst transfer was performed when the cycle number was above two. In this case, the embryos were cultured on a sequential medium: G1 â medium (Irvine Scientific) for the first 2 days and G2 â medium (Irvine Scientific) for the last days of culture. In some cases, blastocyst transfer was programmed but no blastocyst was obtained or the blastocyst quality was not sufficient: xBC or xCC according to Gardner classification (x representing a number between 1 and 5) (Gardner & Schoolcraft, 1999) ; in this case, no embryo transfer was performed (no transfer group). After embryo transfer, the remaining good-quality blastocysts were cryopreserved. A clinical pregnancy was confirmed by increasing plasma beta HCG concentration measured at three successive time points, followed by ultrasound detection of heartbeat, and the delivery rate was used as the outcome of the ART procedure.
Sperm DNA extraction protocol and quantification of the histone-to-protamine ratio To avoid contamination with somatic cells, the process was performed on remaining gradient-selected spermatozoa used for an ART process. The selected sperm samples were stored at À20°C. It is of note that semen samples stored at À20°C could have been used for an ART procedure (Chao et al., 2012) . Furthermore, as the aim of this study was to quantify histone and protamine linked to chromatin, it was not necessary to use the freezing protocol usually performed for an ART procedure as viability was not an issue.
The protocol for separation of the two fractions of nucleoprotein linked to chromatin (histone fraction, HDNA, and the protamine fraction, PDNA) was developed from the protocol reported by Wykes and Krawetz (Wykes & Krawetz, 2003) . The amount of DNA in a sperm nucleus is about 3 pg (Mann, 1964) ; 15 million spermatozoa are therefore necessary to obtain a sufficient amount of DNA, and a maximum of 60 million avoids saturating the columns used for DNA extraction.
A fraction of the thawed spermatozoa was examined by brightfield microscopy to confirm the absence of somatic cell contamination (round cells and leukocytes). Spermatozoon was first washed in 50 mM Tris-HCl pH 8 (Qbiogene, Carlsbad, CA, USA), and after centrifugation (2000 g, 20 min, room temperature), the pellet was resuspended in 4 mL of 10 mM dithiothreitol (DDT) solution (Sigma-Aldrich, Saint-Quentin Fallavier, France), 50 mM Tris-HCl pH 8 (Sigma-Aldrich) and incubated on ice for 15 min to decondense sperm nuclei. Forty microliters of 10% cetyltrimethylammonium bromide (CTAB, Sigma-Aldrich) was added, and the sample was incubated on ice for 30 min to separate the tail from the head sperm DNA. The sample was then centrifuged at 3000 g for 10 min at 4°C. Sperm heads are in the pellet, a fraction of which was examined by brightfield microscopy to confirm the absence of tail and other contaminant products. The pellet was suspended in 4 mL of 0.65 M NaCl (Sigma-Aldrich), 1 mM EDTA (Sigma-Aldrich), 10 mM Tris-HCl pH8, and 0.05% (w/v) digitonin (Sigma-Aldrich) solution, incubated for 15 min at 4°C to permeabilize sperm head membranes, and then centrifuged at 3000 g for 10 min at 4°C. As chromatin linked to histones is located in the periphery of the nucleus and the chromatin linked to protamine is located inside the nucleus, after membrane permeabilization chromatin linked to histones is exposed. This allows separation from the DNA linked to protamines using endonuclease enzymes. Thus, the pellet was then incubated with 10 lL BamH1 (100 U; SigmaAldrich) and 10 lL EcoR1 (100 U; Sigma-Aldrich) at 37°C for 2 h. Following centrifugation at 3000 g for 2 min, the supernatant (containing HDNA) was separated from the pellet (containing PDNA). The supernatant (HDNA fraction) was transferred to a new tube, centrifuged for 2 min at 16,000 g in order to remove all traces of protamine bound to DNA, and then transferred to a new tube. Ten microliters of proteinase K (200 lg/mL; Fisher Scientific, Illkirch, France) and 25 lL of 10% SDS (Sigma-Aldrich) were then added to the HDNA fraction. The pellet containing the PDNA fraction was resuspended in 1 mL of 50 mM Tris-HCl (pH 8.5) buffer with 50 mM NaCl, 0.5 mM EDTA, 0.5% SDS, and 25 lL proteinase K (200 lg/mL). HDNA and PDNA fractions were incubated overnight at 50°C.
The DNA of each fraction was then extracted using the EZNA Blood DNA Mini Kit (Omega Bio-tek, Norcross, GA, USA) according to the manufacturer's protocol. Briefly, 10% of OB protease (Fisher Scientific) was added to each fraction (HDNA and PDNA). BL buffer (Fisher Scientific) was also added according to the manufacturer's instructions. The solution was incubated at 65°C for 30 min. DNA was solubilized with ethanol, then the columns were used to extract DNA according to the fractions: HDNA and PDNA. The HDNA and PDNA fractions were suspended in sterile distilled water supplemented with 0.5 mM EDTA (Sigma-Aldrich). The relative concentration of both fractions, HDNA and PDNA, was then spectrophotometrically determined. The HPR was calculated according the following formula:
HPR ð%Þ ¼ HDNA ðHDNAÞ þ ðPDNAÞ Â 100
Sperm DNA fragmentation analysis Detection of fragmented DNA was performed on the remaining sperm suspension used for the ART procedure (volume between 50 and 60 lL). The cells were smeared on silanized slides. Cells were fixed with 4% formalin (Sigma-Aldrich) for 20 min, then permeabilized with 1% Triton X-100 (SigmaAldrich). Sperm cells with DNA fragmentation were identified by the TUNEL technique using the ApopTag kit (Millipore, Billerica, MA, USA). The cells were first neutralized with the 'balance buffer' and then incubated in a humid chamber at 37°C for 1 h, with the Terminal d-Transferase (TdT) solution to enable the elongation of the sperm DNA. The cells were then incubated with a peroxidase-conjugated anti-digoxigenin antibody for 30 min in a dark humid chamber and then with diaminobenzidine to visualize elongation. Sperm nuclei were stained using Harris hematoxylin (Sigma-Aldrich). The cells were observed under a microscope (Zeiss, Oberkochen, Germany) equipped with a 1009 oil immersion lens. Sperm nuclei with fragmented DNA were colored brown, whereas the other cell nuclei were blue-gray. On each slide, approximately 500 cells were counted and the proportion of spermatozoa with fragmented DNA was determined, allowing calculation of DNA fragmentation index (DFI). For each batch, a positive control and a negative control were performed. The positive control corresponded to the DFI analysis of spermatozoa known to be fragmented. This positive control slide was obtained from spermatozoa with repeatedly high DFI values, and a set of DFI-positive control slides were prepared and used before each TUNEL procedure. For the negative control, the procedure was performed on a slide that did not receive the TdT solution.
Data analysis
Statistical analyses were conducted on clinical and biological data obtained from the MEDIFIRST â database software (Medifirst, Montigny le Bretonneux, France) and using SPSS software (SPSS 18.1, IBM, Chicago, IL, USA). Pearson's or Spearman's correlation coefficient, Student's t-test, ANOVA (with linear and/or quadratic contrast), Tukey's tests, and chi-squared tests were used for univariate analysis. Nonparametric tests were used when the distribution of a variable was not Gaussian. The variables were described as mean AE standard deviation (SD) for quantitative variables and with the distribution of percentage for categorical variables. The statistical analysis was performed separately for each ART procedure (c-IVF and ICSI) between the parameters used in the study and the outcome parameters (blastocyst formation and delivery), and on pooled data (irrespective of the procedure). HPR and DFI parameters were used as categorical variables. The parameters predicting the blastocyst formation were used in a logistic regression to calculate the odds ratio (OR) for predicting delivery. A test was performed when the size of all tested groups was above five; this test was considered significant when p was <0.05. DFI and HPR were ranked in subsets. For DFI, the following subsets were defined: ≤20%, ]20; 30%], and >30%. For HPR, as the true normal range for this parameter is not established, HPR quartiles were used to determine the HPR subset with the best prognosis potential for blastocyst formation. Subsequently, the HPR subsets were regrouped with the aim to obtain the minimum number of HPR subsets with a blastocyst formation rate significantly different between each subset. The z test was used to compare the blastocyst formation rate according to the HPR subsets.
Embryo transfer at D2 or D3 was grouped together as they were performed at the cleavage stage. The fertilization rate was defined as the number of zygotes divided by the number of 438 Andrology, 2018, 6, 436-445 metaphase II oocytes, multiplied by 100. Blastocyst formation rate was defined as the number of cycles with at least one blastocyst formation divided the total number of cycles. The blastulation rate was defined as the number of blastocysts obtained divided by the total number of embryos, multiplied by 100. When the embryo transfer was performed on D2 or D3, the blastocyst formation rate and the blastulation rate were calculated on the remaining embryos. To take into account the bias of the calculation of blastocyst formation rate and blastulation rate when an early transfer was performed, two blastulation rates were calculated, one with all cycles and one with cycles where a transfer at the blastocyst stage was programmed. The investigation of prognosis factors for blastocyst formation was performed on all cycles and on cycles where a blastocyst transfer was programmed.
RESULTS HPR and DFI in donor spermatozoa
For the donor spermatozoa (n = 5), the mean volume was 3.5 mL and the mean concentration was 45.4 million/mL. With each sperm donor, ten children were obtained in an ART procedure (the maximum number of children per sperm donor allowed by French law). The mean HPR was 17.3% (range: 2.4% to 23.2%), and mean DFI was 8.1% (range: 1.6% to 18.8%). Table 1 presents the main results according to the embryo transfer stage. The mean age of men in the study population was 36.1 years, and mean BMI was 25.5. The mean age of women was 33.7 years, and mean BMI was 23.7. The mean number of retrieved oocytes was 13.3, a mean 7.6 embryos were obtained, and a mean 1.9 embryos were transferred. The embryos were transferred on D2/D3 (cleavage stage) for 45.0% of couples (131/291) on D5 (blastocyst stage) for 35.1% (102/ 291) and on D6 for 12.0% (35/291); no embryo transfer was performed for 7.9% (23/291) of cases. For the latter, a delayed transfer was planned, but no blastocyst was obtained; therefore, no embryo transfer could be performed. The HPR value was lowest when the embryo transfer was performed on D5 (mean AE SD: 16.5% AE 16.4%) and highest when the embryo transfer was performed on D6 (24.9% AE 20.7%), and this difference was significant (p < 0.05). For an embryo transfer performed on D2/D3, the mean AE SD HPR value was 19.3% AE 19.1% and was not significantly different from the other HPR values. When no embryo transfer was performed, the mean AE SD HPR value was 18.3% AE 22.7% and was not significantly different from the other HPR values.
ART characteristics
The overall clinical pregnancy rate was 23.4% (68/291). The highest clinical pregnancy rate was obtained with D5 blastocyst transfer (36.3%) that was not significantly different from that obtained with D2/D3 transfer (21.4%); the lowest was obtained with D6 transfer (8.6%) which was significantly different from that obtained with D5 blastocyst transfer (p < 0.001) and not significantly different from that obtained with D2/D3 transfer. The overall delivery rate was 22.3%, corresponding to 65 live births, one triplet, 17 twins, and 45 singletons. A significant difference was found between the D5 blastocyst transfer (35.3%) and D6 blastocyst transfer (5.7%, p < 0.01) delivery rate, and no significant differences were found between D2/D3 transfer (20.6%) and D5 or D6 blastocyst transfer delivery rate. Dx, embryo transfer at day x; BMI, body mass index; No transfer, no embryo transferred due to blocked embryo or altered blastocyst quality; M/mL, million per mL; DFI, DNA fragmentation index; HPR, histone-to-protamine ratio; ART, artificial reproduction technology. Outcome according to ART procedure: c-IVF vs. ICSI Among the 291 ART cycles, 42 c-IVF and 249 ICSI were performed. When a c-IVF was performed, the mean AE SD HPR value was 23.7% AE 20.9%, and when an ICSI procedure was performed, it was 18.1% AE 18.7%; there was no significant difference between these values. Women for whom c-IVF was performed were older (mean AE SD: 35.6 AE 3.6 years) than those for whom an ICSI was performed (33.7 AE 4.4 years, p < 0.01). A lower BMI was found for women for whom a c-IVF was performed (21.9 AE 3.8 vs. 23.9 AE 4.8, p < 0.05). There was no significant difference in the number of retrieved oocytes between those for whom c-IVF was performed (12.8 AE 6.4) and those for whom ICSI was performed (13.3 AE 6.1), as was the case for fertilization rate (62.1% AE 26.2% vs. 58.3% AE 20.6%), number of embryos (7.3 AE 4.5 vs. 7.6 AE 4.4), and number of embryos transferred (2.0 AE 0.4 vs. 1.9 AE 0.5).
Relationship between DFI and ART procedure outcome A technical problem occurred in five cycles that precluded DFI measurement; DFI was therefore measured for 286 cycles. The mean DFI value was 9.3%. Sperm motility was correlated negatively (Pearson's correlation coefficient) with DFI (r = À0.25, p < 0.01), as was HPR (r = À0.12, p < 0.05). A positive correlation was found between DFI and male age (r = 0.13, p < 0.05). No correlation was found between DFI and BMI (r = À0.08, p NS), or between DFI and spermatozoa concentration (r = À0.06, p NS). Table 2 presents the main results according to DFI subsets and ART procedure. For ICSI procedures, the highest proportion of motile spermatozoa was obtained when the DFI was lower or equal to 20% (mean AE SD: 34.4% AE 9.3%), and the lowest proportion of motile spermatozoa (25.7% AE 10.6%) was obtained when the DFI was above 30%, and there was a significant difference between these two values, both between themselves and for the other categories of DFI (p < 0.01). For the c-IVF procedure, the size of DFI subsets was too low to allow the use of statistical tests; the main results are presented in Table 2 . Independently of the ART procedure used, the highest proportion of motile spermatozoa was obtained when the DFI was lower or equal to 20% (mean AE SD: 34.6% AE 9.2%), and the lowest proportion of motile spermatozoa (27.2% AE 10.6%) was obtained when the DFI was above 30%, and there was a significant difference between these two values, both between themselves and for the other categories of DFI (p < 0.01). With regard to ART parameters, there was no significant difference between DFI subsets for the cycle number, total gonadotropin dose, the duration of stimulation, the number of retrieved oocytes, the number of embryos, the fertilization rate, the number of transferred embryos, blastocyst formation, at least one embryo frozen, and the clinical pregnancy rate. When all cycles were included in the statistical analysis, no relationship was found between blastocyst formation rate and DFI subset ( Table 2) .
Relationship between HPR and ART procedure outcome
The HPR value was measured for 291 cycles. For twelve sperm preparations, the proportion of remaining round cells was between 0.1% and 0.5%, and these remaining round cells had no influence on HPR measurement (Table S1 ). The mean HPR was 18.9%. Sperm motility was correlated positively (Spearman's correlation coefficient) with HPR (r = 0.21, p < 0.001; Figure S1 ). There was no significant correlation between HPR and male age, male BMI, or sperm concentration ( Figure S1 ).
To determine the HPR subsets, the blastocyst formation rates according to HPR quartile were calculated. The HPR quartiles were 6%, 11.5%, and 26%. The blastocyst formation rates were 71.2% for HPR< 6%, 87.5% for [6%; 11.5%[, 88.0% for [11.5%; 26%], and 74.6% for HPR>26% (p < 0.05). Each blastocyst formation rate according to the HPR quartile was compared quartile by quartile. The first quartile was compared to the second, the second to the third, and the third to the fourth in order to allow the regrouping of similar quartiles. The second and the third quartiles were regrouped as for these the blastocyst formation rate was similar (p not significant); three HPR subsets were constituted: below 6%, between 6% and 26%, and above 26%. For HPR between 6% and 26%, the blastocyst formation rate was 87.8%, whereas this was 71.2% when the HPR was below 6%, and 75.7% when the HPR was above 26% (p < 0.01). The blastocyst formation rate was significantly different between the central HPR group and the two extreme HPR subsets (HPR [6; 26] vs. HPR<6%, p < 0.05; HPR [6; 26] vs. HPR>26%, p < 0.05); there was no significant difference in the blastocyst formation rate between the two extreme HPR subsets (HPR<6% vs. HPR>26%). Table 3 and Figure S2 present the main results according to the HPR subsets and ART procedures. With regard to ART parameters, there was no significant difference between HPR subsets for total gonadotropin dose, the number of retrieved oocytes, the number of embryos, the fertilization rate, the blastulation rate, the number of transferred embryos, the clinical pregnancy rates, and the delivery rates. Within the 6% to 26% HPR value range, the fertilization and blastocyst formation rates were the highest but not significantly different to values below or above this range. When a c-IVF procedure was performed, the mean AE SD duration of stimulation was significantly different (p < 0.05): 10.6 AE 1.6 (HPR<6%), 11.9 AE 1.3 (HPR [6%; 26%]), and 11.0 AE 1.2 (HPR>26%). When an ICSI procedure was performed, the mean AE SD number of cycles was significantly different (p < 0.001): 1.7 AE 0.9 (HPR<6%), 2.4 AE 1.3 ([6%; 26%]), and 2.2 AE 1.4 (HPR>26%).
Prognosis factors for blastocyst formation
Blastocyst formation was not associated with male parameters and ART procedure type (c-IVF or ICSI). The parameters significantly associated with blastocyst formation in univariate analysis were female age, the total amount of gonadotropin administered, the total number of retrieved oocytes, the number of embryos, and the fertilization rate. In multivariate logistic regression, HPR and the fertilization rate were significantly associated with blastocyst formation: an HPR between 6% and 26% (OR = 2.81, 95% CI [1.32; 6.00], p < 0.01) and greater fertilization rate (OR = 1.03, 95% CI [1.01; 1.04], p < 0.001) was associated with a greater chance of obtaining at least one blastocyst (Table 4) . However, when the analysis was performed on cycles where a transfer at blastocyst stage was programmed, the proportion of cycles with the formation of at least one blastocyst was higher when HPR was between 6% and 26% (96.7%) in comparison with an HPR above 26% (94.3%) and an HPR under 6% (91.2%), but the difference was not statistically different ( Table 5 ).
The blastulation rate was lowest when the embryo transfer was performed on D2/D3 (mean AE SD: 20.8% AE 20.0%) and higher when the embryo transfer was performed on D5 (65.9% AE 22.9%), or on D6 (58.0% AE 26.7; Table 1 ). No significant correlation was found between blastulation rate and HPR (r = À0.02) or DFI (r = À0.01). When a c-IVF was performed, no significant correlation was found between blastulation rate and HPR (r = À0.20) or DFI (r = À0.24), as was the case when an ICSI was performed (HPR: r = 0.01, DFI: r = 0.02). Irrespective of the type of ART procedure used, when the HPR was within the range [6; 26] , the blastocyst formation rate was higher (87.8%) than when HPR, histone-to-protamine ratio; BMI, body mass index; M/mL, million per mL; DFI, DNA fragmentation index; ART, artificial reproduction technology; c-IVF, conventional in vitro fertilization; ICSI, intracytoplasmic sperm injection; NC, p not calculable; NS, p not significant. 
THE IMPACT OF SPERM HISTONES ON EMBRYO DEVELOPMENT
HPR was <6% (71.2%, p < 0.01) and when HPR was >26% (74.6%, p < 0.01; Figure S2 ). When the patients with a D2/D3 embryo transfer were excluded from the statistical analysis, no significant correlation was found between blastocyst formation rate and HPR (r = À0.01) or DFI (r = 0.04). Table 6 presents the main results according to the delivery result. Irrespective of the type of ART procedure used, the delivery rate for a HPR value above 26% was lower (18.3%) than for a HPR value below 6% (21.9%) and between 6 and 26% (24.5%), but this difference was not statistically significant. Similar results were found according to the type of ART procedure used (Figure S2) . Among all examined parameters, none was prognostic for clinical pregnancy/delivery result in univariate analysis and multivariate logistic regression analysis.
Prognosis factors of delivery
DISCUSSION
The results of the present study indicate that HPR value is related to semen characteristics. HPR was positively correlated with the proportion of motile spermatozoa and negatively with DFI. The relationship between HPR and DFI is very interesting. The relationship between these two parameters is not linear. The DFI value was low within a specific range of HPR values and high when the HPR value was outside this specific window. When the HPR value was low and outside the window, the protamine concentration was high. This could be related to excessive activity of topoisomerase that is implicated in the replacement of histones by protamine, which involves the introduction of breaks in the DNA (Yamauchi et al., 2007) . It could also explain the increased level of DNA fragmentation found to be associated with low HPR values herein. When HPR was high and outside the HPR window, the protamine concentration was low so it could be hypothesized that a low HPR value is related to a reduction in chromatin structure stability, which makes sperm DNA more susceptible to DNA damage (Aoki et al., 2005a,b) .
Moreover, the HPR value could allow the determination of whether sperm DNA fragmentation occurs during a testicular or an epididymal process (Ioannou et al., 2016) . As the protamination process occurs during spermatogenesis, when DFI and HPR alterations are associated, a testicular event could be hypothesized, and in this case, the treatment of sperm DNA fragmentation with antioxidant drugs will not be optimal. This example illustrates that, in some cases, a simple cutoff value does not allow the construction of a biological prognosis parameter. An alternate hypothesis is that an abnormal HPR (above 26%) results in the DNA being not tightly packed, which may result in oxidative-mediated DNA damage as compact DNA packing in spermatozoa using protamines is an essential means of natural protection of DNA from free radicals (Oliva, 2006) .
In the current investigation, when all cases were included in the statistical analysis, HPR seemed to be prognostic of 442 Andrology, 2018, 6, 436-445 blastocyst formation instead of the proportion of obtained blastocyst (blastulation rate). HPR and fertilization rate were the only factors found to be significantly associated with blastocyst formation in multivariate analysis. When the HPR value was between 6% and 26%, the probability of blastocyst formation was optimal and decreased when the HPR value was outside this window. Regarding the type of ART procedure (c-IVF or ICSI), the same kind of relationships between HPR and ART parameters was observed. When the study was restricted to cycles with programmed blastocyst transfer, only a trend was found between HPR and blastocyst formation rate, possibly because the number of remaining included cycles does not provide sufficient power for the statistical test. Taken together, these results suggest that suboptimal protamination that implies compensation by histones may involve a defect in the activation of the paternal genome and consequently the development and the implantation of the embryo. If a spermatozoon with an altered HPR value is involved in an ART procedure (in particular ICSI), this could result in a desynchronized paternal genomic expression that alters the embryo development until the blastocyst stage. These defects on remaining sperm histones could affect post-zygotic paternal gene expression (Aoki et al., 2006) . As the histone content is related to epigenetic modifications, all variations of the quantity of remaining histones could have an impact on epigenetic code and thus disturb embryo development (Hammoud et al., 2011; Denomme et al., 2017) . Furthermore, the HPR values were different according to the embryo transfer stage. When no embryo transfer was performed with a low HPR, a maternal effect and/or an unknown male effect on embryo development could be hypothesized. The HPR was highest when the embryo transfer was performed on D6, lowest on D5, and intermediate for an early-stage embryo transfer. We could speculate that the HPR value plays a role in the timing of development. For instance, it may be hypothesized that delayed blastocyst formation found with spermatozoa having a high HPR value could have two main effects. The first effect would be to desynchronize the blastocyst with the uterus implantation windows. The second effect could be that a desynchronized paternal genomic expression occurs which impairs the trophoblastic development and hence embryo implantation. This was suggested by the low clinical pregnancy/delivery rates when a D6 blastocyst was transferred. It is, however, of note that a significant relationship between HPR and clinical pregnancy/delivery was not found. This result is consistent with a previous study (Simon et al., 2011) , yet it could also be due to the number of patients included.
The study does have a certain number of limits. The first is the use of the chromatin separation method described by Wykes and Krawetz (Wykes & Krawetz, 2003) to separate nucleoproteins herein, but also the slight modification of this protocol. The correlation between HPR and the histone-to-protamine ratio determined directly on the extracted proteins separated by PAGE, stained, and quantified has not been investigated. However, the mean HPR value found was not significantly different from 15%, which corresponds to human sperm chromatin that remains linked to histones in specific areas (Wykes & Krawetz, 2003) . Moreover, the variability of HPR value found was in accordance with that reported by de Yebra et al., (1993) . Therefore, indirectly, this strongly suggests that the HPR measurement seems to be reliable. Another aspect to consider when interpreting the data is that the quantity of spermatozoa required is relatively high and therefore was conducted on normal spermatozoa; methodological aspects currently preclude investigation of oligozoospermia. The use herein of early transfer cycles to calculate blastocyst formation and blastocyst formation rate is a bias that underestimates these parameters. To define the range within which the HPR values were a good prognostic factor for blastocyst formation, a statistical methodology based on the quartiles was used. From four subsets of HPR, the number of subsets was reduced to three, and the good prognostic HPR subset was within 6% and 26%. These data suggest that the [6; 26] proposed HPR interval seems to be a physiological interval and not only a statistical one. Moreover, despite these limits, a trend toward an increased HPR with increasing blastocyst formation was found.
CONCLUSIONS
The procedure described in the present study seems to be a reliable evaluation of the HPR. The HPR parameter seems to be correlated to embryonic development up to the blastocyst stage, but its involvement in clinical pregnancy and delivery could not be confirmed. HPR should be further investigated to confirm the relationship with blastocyst formation before it is included as a routine diagnostic parameter in the andrology laboratory setting. After this, the next step will be to investigate the etiologies of HPR alterations in order to propose a treatment which will improve the sperm nucleus quality in order to increase the chance of pregnancy.
SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of this article: Figure S1 . Dispersion plot of histone to protamine ratio (HPR) according to DNA fragmentation index (DFI) (A), semen volume (B), semen concentration (C), and semen motility (D). Figure S2 . Box plot and histogram of histone to protamine ratio (HPR) and main ART parameters: retrieved oocyte (A), fertilization rate (B), blastocyst formation rate (C) and delivery rate (D) according to ART procedure (conventional in vitro fertilization (c-IVF) and intra cytoplasmic sperm injection (ICSI). Table S1 . Histone to protamine ratio (HPR) according to the percentage of remaining contaminating round cells after sperm gradient selection.
